70 related articles for article (PubMed ID: 15302136)
1. 2-(2,6-Dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Rao A; Balzarini J; Carbone A; Chimirri A; De Clercq E; Monforte AM; Monforte P; Pannecouque C; Zappalà M
Antiviral Res; 2004 Aug; 63(2):79-84. PubMed ID: 15302136
[TBL] [Abstract][Full Text] [Related]
2. Novel Thiazolidin-4-ones as Potential Non-nucleoside Inhibitors of HIV-1 Reverse Transcriptase.
Petrou A; Eleftheriou P; Geronikaki A; Akrivou MG; Vizirianakis I
Molecules; 2019 Oct; 24(21):. PubMed ID: 31652782
[TBL] [Abstract][Full Text] [Related]
3. Drug-like property-driven optimization of 4-substituted 1,5-diarylanilines as potent HIV-1 non-nucleoside reverse transcriptase inhibitors against rilpivirine-resistant mutant virus.
Wei L; Wang HL; Huang L; Chen CH; Morris-Natschke SL; Lee KH; Xie L
Bioorg Med Chem Lett; 2017 Jun; 27(12):2788-2792. PubMed ID: 28465101
[TBL] [Abstract][Full Text] [Related]
4. Development of Novel Dihydrofuro[3,4-
Kang D; Sun Y; Feng D; Gao S; Wang Z; Jing L; Zhang T; Jiang X; Lin H; De Clercq E; Pannecouque C; Zhan P; Liu X
J Med Chem; 2022 Feb; 65(3):2458-2470. PubMed ID: 35061384
[TBL] [Abstract][Full Text] [Related]
5. 2,4,5-Trisubstituted Pyrimidines as Potent HIV-1 NNRTIs: Rational Design, Synthesis, Activity Evaluation, and Crystallographic Studies.
Kang D; Ruiz FX; Sun Y; Feng D; Jing L; Wang Z; Zhang T; Gao S; Sun L; De Clercq E; Pannecouque C; Arnold E; Zhan P; Liu X
J Med Chem; 2021 Apr; 64(7):4239-4256. PubMed ID: 33734714
[TBL] [Abstract][Full Text] [Related]
6. Pyrimidine 2,4-Diones in the Design of New HIV RT Inhibitors.
Romeo R; Iannazzo D; Veltri L; Gabriele B; Macchi B; Frezza C; Marino-Merlo F; Giofrè SV
Molecules; 2019 May; 24(9):. PubMed ID: 31052607
[TBL] [Abstract][Full Text] [Related]
7. Design of Biphenyl-Substituted Diarylpyrimidines with a Cyanomethyl Linker as HIV-1 NNRTIs via a Molecular Hybridization Strategy.
Lei Y; Han S; Yang Y; Pannecouque C; De Clercq E; Zhuang C; Chen FE
Molecules; 2020 Feb; 25(5):. PubMed ID: 32111013
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Novel Dihydrothiopyrano[4,3-
Wang Z; Zalloum WA; Wang W; Jiang X; De Clercq E; Pannecouque C; Kang D; Zhan P; Liu X
J Med Chem; 2021 Sep; 64(18):13658-13675. PubMed ID: 34432448
[TBL] [Abstract][Full Text] [Related]
9. Extension into the entrance channel of HIV-1 reverse transcriptase--crystallography and enhanced solubility.
Bollini M; Frey KM; Cisneros JA; Spasov KA; Das K; Bauman JD; Arnold E; Anderson KS; Jorgensen WL
Bioorg Med Chem Lett; 2013 Sep; 23(18):5209-12. PubMed ID: 23899617
[TBL] [Abstract][Full Text] [Related]
10. Discovery and Characterization of Fluorine-Substituted Diarylpyrimidine Derivatives as Novel HIV-1 NNRTIs with Highly Improved Resistance Profiles and Low Activity for the hERG Ion Channel.
Kang D; Ruiz FX; Feng D; Pilch A; Zhao T; Wei F; Wang Z; Sun Y; Fang Z; De Clercq E; Pannecouque C; Arnold E; Liu X; Zhan P
J Med Chem; 2020 Feb; 63(3):1298-1312. PubMed ID: 31935327
[TBL] [Abstract][Full Text] [Related]
11. Exploring novel HIV-1 reverse transcriptase inhibitors with drug-resistant mutants: A double mutant surprise.
Hollander K; Chan AH; Frey KM; Hunker O; Ippolito JA; Spasov KA; Yeh YJ; Jorgensen WL; Ho YC; Anderson KS
Protein Sci; 2023 Dec; 32(12):e4814. PubMed ID: 37861472
[TBL] [Abstract][Full Text] [Related]
12. Efficient discovery of potent anti-HIV agents targeting the Tyr181Cys variant of HIV reverse transcriptase.
Jorgensen WL; Bollini M; Thakur VV; Domaoal RA; Spasov KA; Anderson KS
J Am Chem Soc; 2011 Oct; 133(39):15686-96. PubMed ID: 21853995
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of 2'-substituted cyclobutyl nucleosides and nucleotides as potential anti-HIV agents.
Li Y; Mao S; Hager MW; Becnel KD; Schinazi RF; Liotta DC
Bioorg Med Chem Lett; 2007 Jun; 17(12):3398-401. PubMed ID: 17434736
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of Thiazolo[3, 2-a]Pyrimidine derivatives as novel RNase H inhibitors.
Zhao KX; Zhang YY; Wang JS; Wang S; Corona A; Maloccu S; Tramontano E; Pannecouque C; De Clercq E; Meng G; Wang L; Chen FE
Bioorg Chem; 2024 Jul; 148():107495. PubMed ID: 38805850
[TBL] [Abstract][Full Text] [Related]
15.
Lane T; Makarov V; Nelson JAE; Meeker RB; Sanna G; Riabova O; Kazakova E; Monakhova N; Tsedilin A; Urbina F; Jones T; Suchy A; Ekins S
J Med Chem; 2023 May; 66(9):6193-6217. PubMed ID: 37130343
[TBL] [Abstract][Full Text] [Related]
16. Optimization of diarylazines as anti-HIV agents with dramatically enhanced solubility.
Bollini M; Cisneros JA; Spasov KA; Anderson KS; Jorgensen WL
Bioorg Med Chem Lett; 2013 Sep; 23(18):5213-6. PubMed ID: 23937980
[TBL] [Abstract][Full Text] [Related]
17. Identification of two HIV inhibitors that also inhibit human RNaseH2.
Kim J; Yoon J; Ju M; Lee Y; Kim TH; Kim J; Sommer P; No Z; Cechetto J; Han SJ
Mol Cells; 2013 Sep; 36(3):212-8. PubMed ID: 24008364
[TBL] [Abstract][Full Text] [Related]
18. A highly facile approach to the synthesis of novel 2-(3-benzyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-N-phenylacetamides.
Novikov MS; Babkov DA; Paramonova MP; Chizhov AO; Khandazhinskaya AL; Seley-Radtke KL
Tetrahedron Lett; 2013 Feb; 54(6):576-578. PubMed ID: 32287444
[TBL] [Abstract][Full Text] [Related]
19.
Ahmad G; Sohail M; Bilal M; Rasool N; Qamar MU; Ciurea C; Marceanu LG; Misarca C
Molecules; 2024 May; 29(10):. PubMed ID: 38792094
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and molecular docking studies of quinoline derivatives as HIV non-nucleoside reverse transcriptase inhibitors.
Bhardwaj N; Choudhary D; Pathania A; Baranwal S; Kumar P
Turk J Chem; 2020; 44(6):1623-1641. PubMed ID: 33488258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
